Literature DB >> 25881722

Cellular uptake and intracellular trafficking of oligonucleotides.

R L Juliano1, K Carver2.   

Abstract

Oligonucleotides manifest much promise as potential therapeutic agents. However, understanding of how oligonucleotides function within living organisms is still rather limited. A major concern in this regard is the mechanisms of cellular uptake and intracellular trafficking of both 'free' oligonucleotides and oligonucleotides associated with various polymeric or nanocarrier delivery systems. Here we review basic aspects of the mechanisms of endocytosis and intracellular trafficking and how insights from these processes can be used to understand oligonucleotide delivery. In particular we discuss opportunities for escape of oligonucleotides from endomembrane compartments and describe recent studies using small molecules to enhance oligonucleotide effects.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Delivery; Endocytosis; Oligonucleotide; Pharmacology; Therapeutics; Trafficking

Mesh：

Substances：

Year:  2015        PMID： 25881722      PMCID： PMC4504789          DOI： 10.1016/j.addr.2015.04.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


  145 in total

Review 1.  Rab proteins as membrane organizers.

Authors:  M Zerial; H McBride
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

2.  Cytosolic malate dehydrogenase confers selectivity of the nucleic acid-conducting channel.

Authors:  Basil Hanss; Edgar Leal-Pinto; Avelino Teixeira; Robert E Christian; Jeffery Shabanowitz; Donald F Hunt; Paul E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 3.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

Review 4.  Molecular structure, function, and dynamics of clathrin-mediated membrane traffic.

Authors:  Tom Kirchhausen; David Owen; Stephen C Harrison
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-05-01       Impact factor: 10.005

5.  Caenorhabditis elegans SID-2 is required for environmental RNA interference.

Authors:  William M Winston; Marie Sutherlin; Amanda J Wright; Evan H Feinberg; Craig P Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

Review 6.  Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction.

Authors:  Stefan Kunz
Journal:  Virology       Date:  2009-03-25       Impact factor: 3.616

7.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

8.  Determination of cellular uptake and intracellular levels of Cenersen (Aezea(®), EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cells.

Authors:  Houda Alachkar; Zhiliang Xie; Guido Marcucci; Kenneth K Chan
Journal:  J Pharm Biomed Anal       Date:  2012-08-19       Impact factor: 3.935

9.  Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells.

Authors:  Oleg O Glebov; Nicholas A Bright; Benjamin J Nichols
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

Review 10.  Small RNAs in transcriptional gene silencing and genome defence.

Authors:  Danesh Moazed
Journal:  Nature       Date:  2009-01-22       Impact factor: 49.962
View more
  45 in total

Review 1.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

Review 2.  Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents.

Authors:  Dakota J Brock; Helena M Kondow-McConaghy; Elizabeth C Hager; Jean-Philippe Pellois
Journal:  Bioconjug Chem       Date:  2018-12-06       Impact factor: 4.774

Review 3.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

Review 4.  Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.

Authors:  R L Juliano
Journal:  Nucleic Acid Ther       Date:  2018-04-30       Impact factor: 5.486

5.  6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.

Authors:  Xiaowei Zhang; Daniela Castanotto; Sangkil Nam; David Horne; Cy Stein
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 6.  Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Authors:  Xiaoxin Li; Hongzhao Qi; Weigang Cui; Zhibin Wang; Xiuxiu Fu; Tianxiang Li; Huibo Ma; Yanyan Yang; Tao Yu
Journal:  Mol Ther       Date:  2022-08-01       Impact factor: 12.910

Review 7.  An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions.

Authors:  Miguel A Ortega; Oscar Fraile-Martinez; Cielo Garcia-Montero; Miguel Angel Alvarez-Mon; Ana Maria Gomez-Lahoz; Agustin Albillos; Guillermo Lahera; Javier Quintero; Jorge Monserrat; Luis G Guijarro; Melchor Alvarez-Mon
Journal:  Membranes (Basel)       Date:  2022-05-25

Review 8.  Non-coding RNAs as drug targets.

Authors:  Masayuki Matsui; David R Corey
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

Review 9.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

Review 10.  Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.

Authors:  Jeremy P Bost; Hanna Barriga; Margaret N Holme; Audrey Gallud; Marco Maugeri; Dhanu Gupta; Taavi Lehto; Hadi Valadi; Elin K Esbjörner; Molly M Stevens; Samir El-Andaloussi
Journal:  ACS Nano       Date:  2021-09-10       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.